Nuance (NUAN +2.2%) trades higher following the purchase of rival clinical transcription/voice...

|About: Nuance Communications, Inc. (NUAN)|By:, SA News Editor

Nuance (NUAN +2.2%) trades higher following the purchase of rival clinical transcription/voice recognition solutions provider M*Modal (MODL) by JPMorgan's P-E arm. Deutsche (Buy) notes the deal's valuation (2x estimated FY13 sales) is in-line with the that paid by Nuance for recent acquisitions, and thinks it's evidence P-E firms are "becoming more active" in the medical transcription and records space.